Interaction of pseudolaric acid B with the colchicine site of tubulin

Biochemical Pharmacology

Volumn 84, Issue 4, 2012, Pages 444-450

  Sarkar, Taradas ^a   Nguyen, Tam Luong ^b   Su, Zhi Wei ^c   Hao, Jun ^c   Bai, Ruoli ^a   Gussio, Rick ^a   Qiu, Samuel X ^c   Hamel, Ernest ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b SAIC FREDERICK INC   (United States)

^c INSTITUTE OF GEOLOGY AND GEOPHYSICS   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TUBULIN; BETA TUBULIN; COLCHICINE; COMBRETASTATIN A4; PSEUDOLARIC ACID B; TUBULIN;

ANTIPROLIFERATIVE ACTIVITY; ARTICLE; BINDING SITE; CELL CULTURE; CELL CYCLE ARREST; COMPLEX FORMATION; CRYSTAL STRUCTURE; CYTOTOXICITY; DRUG PROTEIN BINDING; DRUG STRUCTURE; HUMAN; HUMAN CELL; IC 50; MICROTUBULE; MICROTUBULE ASSEMBLY; MITOSIS; PHARMACOPHORE; PRIORITY JOURNAL;

BINDING SITES; CELL LINE, TUMOR; CELL PROLIFERATION; COLCHICINE; DITERPENES; FLUORESCENCE; HUMANS; KINETICS; MITOSIS; MODELS, MOLECULAR; PINACEAE; PROTEIN BINDING; STATHMIN; TUBULIN; TUBULIN MODULATORS;

EID: 84864131939     PISSN: 00062952     EISSN: 18732968     Source Type: Journal    
DOI: 10.1016/j.bcp.2012.05.014     Document Type: Article

References (27)

1. E. Hamel An overview of compounds that interact with tubulin and their effects on microtubule assembly A.T. Fojo, Microtubule targets in cancer therapy 2008 Humana Press Totowa, NJ 1 20
2. V.K.W. Wong, P. Chiu, S.S.M. Chung, L.M.C. Chow, Y.-Z. Zhao, and B.B. Yang Pseudolaric acid B, a novel microtubule-destabilizing agent that circumvents multidrug resistance phenotype and exhibits antitumor activity in vivo Clin Cancer Res 11 2005 6002 6011
3. Y-G. Tong, X-W. Zhang, M-Y. Geng, J-M. Yue, X-L. Xin, and F. Tian Pseudolarix acid B, a new tubulin-binding agent, inhibits angiogenesis by interacting with a novel binding site on tubulin Mol Pharmacol 69 2006 1226 1233
4. B. Bhattacharyya, and J. Wolff Promotion of fluorescence upon binding of colchicine to tubulin Proc Natl Acad Sci USA 71 1974 2627 2631
5. R.B.G. Ravelli, B. Gigant, P.A. Curmi, I. Jourdain, S. Lachkar, and A. Sobel Insight into tubulin regulation from a complex with colchicine and a stathmin-like domain Nature 428 2004 198 202
6. E. Hamel, and C.M. Lin Separation of active tubulin and microtubule-associated proteins by ultracentrifugation and isolation of a component causing the formation of microtubule bundles Biochemistry 23 1984 4173 4184
7. E. Li, A.M. Clark, and C.D. Hufford Antifungal evaluation of pseudolaric acid B, a major constituent of Pseudolarix kaempferi J Nat Prod 58 1995 57 67
8. P. Verdier-Pinard, J-Y. Lai, H-D. Yoo, J. Yu, B. Márquez, and D.G. Nagle Structure-activity analysis of the interaction of curacin A, the potent colchicine site antimitotic agent, with tubulin and effects of analogs on the growth of MCF-7 breast cancer cells Mol Pharmacol 53 1998 62 76
9. P. Skehan, R. Storeng, D. Scudiero, A. Monks, J. McMahon, and D. Vistica New colorimetric cytotoxicity assay for anticancer-drug screening J Natl Cancer Inst 82 1990 1107 1112
10. T.L. Nguyen, C. McGrath, A.R. Hermone, J.C. Burnett, D.W. Zaharevitz, and B.W. Day A common pharmacophore for a diverse set of colchicine site inhibitors using a structure-based approach J Med Chem 48 2005 6107 6116
11. E. Hamel Evaluation of antimitotic agents by quantitative comparisons of their effects on the polymerization of purified tubulin Cell Biochem Biophys 38 2003 1 22
12. G. La Regina, M.C. Edler, A. Brancale, S. Kandil, A. Coluccia, and F. Piscitelli Arylthioindole inhibitors of tubulin polymerization. 3. Biological evaluation, structure-activity relationships, and molecular modeling studies J Med Chem 50 2007 2865 2874
13. M. Dixon, E.C. Webb, C.J.R. Thorne, and K.F. Tipton Enzymes 3rd ed. 1979 Academic Press New York
14. R. Bai, G.R. Pettit, and E. Hamel Binding of dolastatin 10 to tubulin at a distinct site for peptide antimitotic agents near the exchangeable nucleotide and vinca alkaloid sites J Biol Chem 265 1990 17141 17149
15. C.M. Lin, H.H. Ho, G.R. Pettit, and E. Hamel The antimitotic natural products combretastatin A-4 and combretastatin A-2: studies on the mechanism of their inhibition of the binding of colchicine to tubulin Biochemistry 28 1989 6984 6991
16. S.B. Hastie Interactions of colchicine with tubulin Pharmacol Ther 51 1991 377 401
17. G-J. Kang, Z. Getahun, A. Muzaffar, A. Brossi, and E. Hamel N-acetylcolchinol O-methyl ether and thiocolchicine, potent analogs of colchicine modified in the C ring: evaluation of the mechanistic basis for their enhanced biological properties J Biol Chem 265 1990 10255 10259
18. C.M. Lin, G.J. Kang, M.C. Roach, J.B. Jiang, D.P. Hesson, and R.F. Ludueña Investigation of the mechanism of the interaction of tubulin with derivatives of 2-styrylquinazolin-4(3H)-one Mol Pharmacol 40 1991 827 832
19. R.M. Chabin, and S.B. Hastie Association of thiocolchicine with tubulin Biochem Biophys Res Commun 161 1989 544 550
20. S. Bane, D. Puett, T. Macdonald, and R.C. Williams Jr. Binding to tubulin of the colchicine analog 2-methoxy-5-(2′,3′,4′- trimethoxyphenyl)tropone: thermodynamic and kinetic aspects J Biol Chem 259 1984 7391 7398
21. A. Banerjee, L. Barnes, and R.F. Ludueña The role of the B-ring of colchicine in the stability of the colchicine-tubulin complex Biochim Biophys Acta 913 1987 138 144
22. Y. Engelborghs, and T.J. Fitzgerald A fluorescence stopped flow study of the competition and displacement kinetics of polophyllotoxin and the colchicine analog 2-methoxy-5-(2′,3′,4′-trimethoxyphenyl)tropone on tubulin J Biol Chem 262 1987 5204 5209
23. M. Kavallaris Microtubules and resistance to tubulin-binding agents Nat Rev Cancer 10 2010 1 11
24. A. Banerjee, and R.F. Luduena Kinetics of colchicine binding to purified β-tubulin isotypes from bovine brain J Biol Chem 267 1992 13335 13339
25. K. Xu, P.M. Schwartz, and R.F. Ludueña Interaction of nocodazole with tubulin isotypes Drug Dev Res 55 2002 91 96
26. A. Banerjee, M.C. Roach, K.A. Wall, M.A. Lopata, D.W. Cleveland, and R.F. Ludueña A monoclonal antibody against the type II isotype of β-tubulin. Preparation of isotypically altered tubulin J Biol Chem 263 1988 3029 3034
27. L. Hiser, A. Aggarwal, R. Young, A. Frankfurter, A. Spano, and J.J. Correia Comparison of β-tubulin mRNA and protein levels in 12 human cancer cell lines Cell Motil Cytoskeleton 63 2006 41 52